Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

A “very large” number of Indians are likely to remain protected from Omicron or any other variant of COVID-19 and there is no need to panic, eminent virologist Dr Shahid Jameel has said.
Jameel, who is the former head of the advisory group to the Indian SARS-COV-2 Genomics Consortia (INASACOG), said people must be cautious and keep wearing masks.
"While we should be cautious, there is no need to panic. India's second wave due to the Delta variant was huge, infecting more people than we imagined. This is reflected in the fourth National Sero-survey that showed 67 per cent of Indians to have Covid antibodies. That is about 930-940 million people at a time when the vaccination levels were very low, and so it came mainly from infection," he told PTI in an interview.
"More recently, Delhi showed 97 per cent with antibodies, Mumbai around 85-90 per cent and so on. All this means that a very large fraction of Indians will be protected from severe disease caused by Omicron or any other variant," Jameel said.
A new variant of COVID-19, feared to have a high amount of spike mutations, has been detected in South Africa. On November 26, the WHO had designated B.1.1.529 as a variant of concern and named it Omicron.
Speaking on the effectiveness of vaccines against the new variant, Jameel said more data is awaited but vaccine effectiveness against the variant may dip by a few points. However, vaccines will not become useless, he said.
"We don't have this data available yet. It may take another one to two weeks for the first laboratory results to become available. My hunch is that vaccine effectiveness against this variant may dip a few points, but vaccines will not become useless. They will continue to protect from severe disease," he said.
On how India can prepare to tackle the new variant, he said people should not panic, and continue to wear mask while the government should increase the rate of vaccination.
"We are fortunate to have sufficient vaccines and the ability to vaccinate. Along this line, it may help to reduce the duration between two doses of Covishield from 16 weeks to 12 weeks. This will get more people vaccinated quickly, especially those in vulnerable age groups (elderly), those with comorbidities and those in high risk occupations (health care)," he said.
On what role a booster dose of vaccine can play against the new variant to tackle waning immunity against COVID-19, he said booster shots help, but it is more important to first get more people vaccinated with two doses.
"Further, about 90 per cent of doses in India are Covishield, and this has limited use as a booster. For that we will need either RNA, DNA or protein vaccines. For the moment, just make sure more and more people get the two doses," he said.Responding to reports claiming that the variant mainly affects people below 25 years of age, he said there is no data available on the subject."So far, the few known patients are in this age group. I doubt it will pose a bigger threat to children who naturally have no or mild disease to this virus," Jameel said.

Eminent virologist Shahid Jameel on Omicron: 'very large' number of Indians may be protected

Eminent virologist Dr Shahid Jameel has said a&nbsp;'very large' number of Indians are likely to remain protected from Omicron or any other variant of Covid-19 and there is no need to panic.
Jameel, who is the former head of the advisory group to the Indian SARS-COV-2 Genomics Consortia, said people must be cautious and keep wearing masks.
A new variant of Covid-19, feared to have a high amount of spike mutations, has been detected in South Africa. On November 26, the WHO had designated B.1.1.529 as a variant of concern and named it Omicron. Stating that Delhi recently showed 97 per cent with antibodies, and &nbsp;Mumbai around 85-90 per cent, Jameel&nbsp;said this&nbsp;means that a very large fraction of Indians will be protected from severe disease caused by Omicron or any other variant.
Speaking on the effectiveness of vaccines against the new variant, Jameel said more data is awaited but vaccine effectiveness against the variant may dip by a few points. However, vaccines will not become useless.

Jameel, who is the former head of the advisory group to the Indian SARS-COV-2 Genomics Consortia, said people must be cautious and keep wearing masks.

A &ldquo;very large&rdquo; number of Indians are likely to remain protected from Omicron or any other variant of COVID-19 and there is no need to panic, eminent virologist Dr Shahid Jameel has said.
 Jameel, who is the former head of the advisory group to the Indian SARS-COV-2 Genomics Consortia (INASACOG), said people must be cautious and keep wearing masks.
Also Watch:&nbsp;<a href="https://www.editorji.com/india-news/omicron-scare-1000-landed-in-mumbai-from-africa-in-15-days-100-tested-so-far-1638248500234">Omicron scare: 1000 landed in Mumbai from Africa in 15 days, 100 tested so far</a>
 "While we should be cautious, there is no need to panic. India's second wave due to the Delta variant was huge, infecting more people than we imagined. This is reflected in the fourth National Sero-survey that showed 67 per cent of Indians to have Covid antibodies. That is about 930-940 million people at a time when the vaccination levels were very low, and so it came mainly from infection," he told PTI in an interview.
 "More recently, Delhi showed 97 per cent with antibodies, Mumbai around 85-90 per cent and so on. All this means that a very large fraction of Indians will be protected from severe disease caused by Omicron or any other variant," Jameel said.
 A new variant of COVID-19, feared to have a high amount of spike mutations, has been detected in South Africa. On November 26, the WHO had designated B.1.1.529 as a variant of concern and named it Omicron.
 Speaking on the effectiveness of vaccines against the new variant, Jameel said more data is awaited but vaccine effectiveness against the variant may dip by a few points. However, vaccines will not become useless, he said.
 "We don't have this data available yet. It may take another one to two weeks for the first laboratory results to become available. My hunch is that vaccine effectiveness against this variant may dip a few points, but vaccines will not become useless. They will continue to protect from severe disease," he said.
 On how India can prepare to tackle the new variant, he said people should not panic, and continue to wear mask while the government should increase the rate of vaccination.
 "We are fortunate to have sufficient vaccines and the ability to vaccinate. Along this line, it may help to reduce the duration between two doses of Covishield from 16 weeks to 12 weeks. This will get more people vaccinated quickly, especially those in vulnerable age groups (elderly), those with comorbidities and those in high risk occupations (health care)," he said.
 On what role a booster dose of vaccine can play against the new variant to tackle waning immunity against COVID-19, he said booster shots help, but it is more important to first get more people vaccinated with two doses.
 "Further, about 90 per cent of doses in India are Covishield, and this has limited use as a booster. For that we will need either RNA, DNA or protein vaccines. For the moment, just make sure more and more people get the two doses," he said. Responding to reports claiming that the variant mainly affects people below 25 years of age, he said there is no data available on the subject. "So far, the few known patients are in this age group. I doubt it will pose a bigger threat to children who naturally have no or mild disease to this virus," Jameel said.

Shahid Jameel, an eminent virologist, while speaking to&nbsp;Vikaram&nbsp;Chandra on NewsGuru, pointed out three aspects on which the predicted third wave of coronavirus&nbsp;in India depends. He said the timing and magnitude of the third wave would depend upon the population that is still susceptible, i.e. unexposed or not vaccinated, the Covid-19 appropriate behaviour as different parts of the country open up after lockdown&nbsp;and lastly whether any more transmissible or &lsquo;infectious&rsquo; variants emerge.
&ldquo;The first factor can be addressed by public policy of vaccinating at scale. The second will depend upon individual choices. And the third is beyond our control as mutations in viruses take place randomly," Jameel, who is professor at Ashoka&nbsp;University explained on NewsGuru.&nbsp;

3rd Covid-19 wave depends on three things: Hear out India's leading virologist Dr Shahid Jameel

Eminent virologist Shahid Jameel&nbsp;pointed out three aspects on which the predicted third wave of coronavirus&nbsp;in India depends.&nbsp;

Shahid Jameel, an eminent virologist, while speaking to&nbsp;Vikram&nbsp;Chandra on NewsGuru, pointed out three aspects on which the predicted third wave of coronavirus&nbsp;in India depends. He said the timing and magnitude of the third wave would depend upon the population that is still susceptible, i.e. unexposed or not vaccinated, the Covid-19 appropriate behaviour as different parts of the country open up after lockdown&nbsp;and lastly whether any more transmissible or &lsquo;infectious&rsquo; variants emerge.
&ldquo;The first factor can be addressed by public policy of vaccinating at scale. The second will depend upon individual choices. And the third is beyond our control as mutations in viruses take place randomly," Jameel, who is professor at Ashoka&nbsp;University explained on NewsGuru.&nbsp;

India's top virologist Shahid Jameel has resigned from a forum of scientific advisers set up by the government to detect variants of the coronavirus.
The resignation came weeks after Dr Jameel questioned the govt's handling of the pandemic. Dr Jameel was the chief of the scientific advisory group known as INSACOG.
He has declined to to give a reason for his resignation, reports said.
News agency Reuters had reported earlier this month that INSACOG had warned government officials in early March of a new and more contagious variant of the coronavirus taking hold in the country. The variant, B.1.617, is behind the deadly second Covid wave in the country.
Asked why the government did not respond more forcefully to the findings, Dr Jameel had told Reuters that he was concerned that authorities were not paying enough attention to the evidence as they set policy.

Top virologist Shahid Jameel quits govt panel after criticising Covid handling  

India's top virologist Shahid Jameel has resigned from a forum of scientific advisers set up by the government to detect variants of the coronavirus.

Top virologist quits govt panel after criticising Covid-19 handling  

India's top virologist Shahid Jameel has resigned from a forum of scientific advisers set up by the government to detect variants of the coronavirus. The resignation came weeks after Dr Jameel questioned the govt's handling of the pandemic. Dr Jameel was the chief of the scientific advisory group known as INSACOG. He has declined to to give a reason for his resignation, reports said. News agency Reuters had reported earlier this month that INSACOG had warned government officials in early March of a new and more contagious variant of the coronavirus taking hold in the country. The variant, B.1.617, is behind the deadly second Covid wave in the country. Asked why the government did not respond more forcefully to the findings, Dr Jameel had told Reuters that he was concerned that authorities were not paying enough attention to the evidence as they set policy.

India's top virologist Shahid Jameel has resigned from a forum of scientific advisers set up by the government to detect variants of the coronavirus.
The resignation came weeks after Dr Jameel questioned the govt's handling of the pandemic. Dr Jameel was the chief of the scientific advisory group known as INSACOG.
He has declined to to give a reason for his resignation, reports said.
News agency Reuters had reported earlier this month that INSACOG had warned government officials in early March of a new and more contagious variant of the coronavirus taking hold in the country. The variant, B.1.617, is behind the deadly second Covid wave in the country.
Asked why the government did not respond more forcefully to the findings, Dr Jameel had told Reuters that he was concerned that authorities were not paying enough attention to the evidence as they set policy.

shahid jameel

Categories